EGFR and lung cancer: Regarding the association between EZH2 expression and the signaling pathway downstream of EGFR, Riquelme et al. recently reported that oncogenic KRAS regulates EZH2 expression in lung cancer and that different amino acid substitutions in KRAS mutants differentially modulate EZH2 expression [25].